RetinalGenix Technologies (RTGN) Research & Development (2020 - 2026)
RetinalGenix Technologies (RTGN) reported Research & Development of $66,406 for Q2 2026, up 360.2% from $14,430 a year earlier but down 43.3% from the prior quarter.
Powered by 
Analysis
RetinalGenix Technologies (RTGN) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, RetinalGenix Technologies' Research & Development came in at $238,866, up 1.7% year-over-year; for FY2025, it was $83,040, down 77.8% from FY2024.
- Research & Development has declined for three consecutive years, with a five-year compound annual growth rate of -28.1% (FY2020 to FY2025).
- By year, Research & Development came in at $373,271 in FY2024 (-28.8%), $524,183 in FY2023 (-35.2%), $809,255 in FY2022 (+8.2%) and $747,808 in FY2021 (+73.3%).
- Five-year quarterly Research & Development spans a low of $13,214 in Q1 2025 and a high of $317,819 in Q4 2022.
- Year over year, Research & Development gained in four of the last eight quarters, with growth averaging 117.6%.
- The high point for year-over-year Research & Development in five years was Q1 2026 (growth of 785.9%); the low point was Q1 2025 (a decline of 84.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $117,064 (Q1 2026), $34,942 (Q4 2025) and $20,454 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 258.00 Mn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 278.90 Mn |
| 10 | RetinalGenix Technologies | 75.19 Mn | 75.14 Mn | - | 66,406.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66,406.00 |
| Mar 31, 2026 | 117,064.00 |
| Dec 31, 2025 | 34,942.00 |
| Sep 30, 2025 | 20,454.00 |
| Jun 30, 2025 | 14,430.00 |
| Mar 31, 2025 | 13,214.00 |
| Dec 31, 2024 | 104,271.00 |
| Sep 30, 2024 | 102,977.00 |
| Jun 30, 2024 | 82,926.00 |
| Mar 31, 2024 | 83,097.00 |
| Dec 31, 2023 | 53,896.00 |
| Sep 30, 2023 | 89,778.00 |
| Jun 30, 2023 | 152,577.00 |
| Mar 31, 2023 | 227,932.00 |
| Dec 31, 2022 | 317,819.00 |
| Sep 30, 2022 | 198,504.00 |
| Jun 30, 2022 | 135,439.00 |
| Mar 31, 2022 | 157,493.00 |
| Dec 31, 2021 | 182,244.00 |
| Sep 30, 2021 | 200,899.00 |
API Access
RetinalGenix Technologies Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();